Pharmaceutical composition
Patent 5698225 Issued on December 16, 1997. Estimated Expiration Date: 
February 3, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 3, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPeptic ulcer treatment method Derivatives of 19,20-Bis-nor-prostanoic acid with antiulcer and anorectic activity, process for their preparation and pharmaceutical compositions thereof Gastric mucosa protective agents Anti-ulcer composition Stabilized enteric coated aspirin granules and process for preparation Pharmaceutical tablet composition Patent #: 5601843 Inventors
ApplicationNo. 794027 filed on 02/03/1997US Classes:424/475, Organic coatings424/464, Tablets, lozenges, or pills424/472, Layered unitary dosage forms424/474, Coated pills or tablets424/476, Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate)514/573Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.)ExaminersPrimary: Kishore, Gollamudi S.Attorney, Agent or FirmInternational ClassesA61K 009/30A61K 009/28 AbstractA pharmaceutical composition including a core of an NSAID selected from diclofenac and piroxicam which core is surrounded by a mantle coating of a prostaglandin, wherein an intermediate coating can be present between the NSAID core and prostaglandin mantle coating. | |
